Edwards Lifesciences
1,197 hedge funds and large institutions have $36.1B invested in Edwards Lifesciences in 2025 Q1 according to their latest regulatory filings, with 120 funds opening new positions, 385 increasing their positions, 485 reducing their positions, and 124 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
4% less capital invested
Capital invested by funds: $37.5B → $36.1B (-$1.4B)
2% less funds holding
Funds holding: 1,221 → 1,197 (-24)
21% less repeat investments, than reductions
Existing positions increased: 385 | Existing positions reduced: 485
Holders
1,197
Holding in Top 10
10
Calls
$257M
Puts
$178M
Top Buyers
| 1 | +$509M | |
| 2 | +$304M | |
| 3 | +$284M | |
| 4 |
Millennium Management
New York
|
+$230M |
| 5 |
Jennison Associates
New York
|
+$184M |
Top Sellers
| 1 | -$292M | |
| 2 | -$199M | |
| 3 | -$175M | |
| 4 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
-$163M |
| 5 |
A
AustralianSuper
Melbourne,
Australia
|
-$80.6M |